7Baggers
 Stifel raises Neumora Therapeutics stock price target to $3 from $2  Investing.com Nigeria Mon, 17 Nov 2025 15:55:57 GMT
 Neumora Therapeutics (NASDAQ:NMRA) Insider Sells 114,703 Shares  MarketBeat Sat, 15 Nov 2025 23:46:11 GMT
 Published on: 2025-11-14 18:32:34  newser.com Sat, 15 Nov 2025 00:32:34 GMT
 LB Pharma, Celldex hire commercial heads as launch plans ramp up  Fierce Pharma Fri, 14 Nov 2025 16:00:00 GMT
 HC Wainwright Has Optimistic Outlook of NMRA FY2025 Earnings  MarketBeat Thu, 13 Nov 2025 12:57:19 GMT
 Neumora Therapeutics Reports Q3 2025 Progress and Financials  TipRanks Wed, 12 Nov 2025 03:54:45 GMT
 Neumora Therapeutics: A Deep Dive (NASDAQ:NMRA)  Seeking Alpha Tue, 11 Nov 2025 15:58:32 GMT
 H.C. Wainwright Sticks to Its Buy Rating for Neumora Therapeutics, Inc. (NMRA)  The Globe and Mail Tue, 11 Nov 2025 01:40:39 GMT
 neumora therapeutics reports q3 eps (35c), consensus (34c)  TipRanks Thu, 06 Nov 2025 14:13:02 GMT
 published on: 2025-11-05 01:27:59  newser.com Wed, 05 Nov 2025 07:27:59 GMT
 published on: 2025-11-05 00:13:28  newser.com Wed, 05 Nov 2025 06:13:28 GMT
 published on: 2025-10-31 04:44:03  newser.com Fri, 31 Oct 2025 09:44:03 GMT
 published on: 2025-10-31 03:53:08  newser.com Fri, 31 Oct 2025 08:53:08 GMT
 neumora to initiate phase 1 study of oral obesity pill  MSN Thu, 30 Oct 2025 10:36:46 GMT
 Neumora Therapeutics Stock (NMRA) Opinions on Obesity Drug Data Release  Quiver Quantitative Thu, 30 Oct 2025 07:00:00 GMT
 Guggenheim upgrades Neumora Therapeutics, Inc. (NMRA) to a Buy  The Globe and Mail Thu, 30 Oct 2025 07:00:00 GMT
 published on: 2025-10-30 01:45:00  newser.com Thu, 30 Oct 2025 06:45:00 GMT
 published on: 2025-10-30 01:21:45  newser.com Thu, 30 Oct 2025 06:21:45 GMT
 major stakeholders make bold moves in neumora therapeutics!  TipRanks Thu, 30 Oct 2025 02:12:27 GMT
 Major Stakeholders Make Bold Moves in Neumora Therapeutics!  TipRanks Wed, 29 Oct 2025 07:00:00 GMT
 Neumora Therapeutics (NASDAQ:NMRA) Price Target Raised to $8.00  MarketBeat Wed, 29 Oct 2025 07:00:00 GMT
 14 stocks under $5 with highest upside potential  Insider Monkey Wed, 29 Oct 2025 00:33:45 GMT
 published on: 2025-10-27 23:36:44  newser.com Tue, 28 Oct 2025 04:36:44 GMT
 neumora initiates phase 1 study of second m4 pam compound by investing.com  Investing.com Canada Tue, 28 Oct 2025 00:03:31 GMT
 neumora’s obesity drug shows up to 26% weight loss in preclinical studies  Investing.com Canada Tue, 28 Oct 2025 00:00:56 GMT

Neumora Therapeutics, Inc.
(NASDAQ:NMRA) 

NMRA stock logo

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

Founded: 2019
IPO Price: $17 (Sep 15, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends